Abstract:The study provides quantitative data of immune‐associated proteins such as major histocompatibility complex (MHC)‐1, (MHC)‐2 and intercellular adhesion molecule (ICAM)‐1 at protein and gene levels. The findings can be integrated into our pathophysiological understanding of IIM. There is evidence that vascular pathology, seen in ASyS, DM and COVID19, may be associated with an ICAM‐1‐mediated endothelial activation. Furthermore, our data introduce ICAM‐1 as a new specific diagnostic marker for morphological classification of myositis. Aims Diagnosis of idiopathic inflammatory myopathies (IIM) is based on morphological characteristics and the evaluation of disease‐related proteins. However, although broadly applied, substantial bias is imposed by the respective methods, observers and individual staining approaches. We aimed to quantify the protein levels of major histocompatibility complex (MHC)‐1, (MHC)‐2 and intercellular adhesion molecule (ICAM)‐1 using an automated morphometric method to mitigate bias. Methods Double immunofluorescence staining was performed on whole muscle sections to study differences in protein expression in myofibre and endomysial vessels. We analysed all IIM subtypes including dermatomyositis (DM), anti‐synthetase syndrome (ASyS), inclusion body myositis (IBM), immune‐mediated‐necrotising myopathy (IMNM), dysferlinopathy (DYSF), SARS‐CoV‐2 infection and vaccination‐associated myopathy. Biopsies with neurogenic atrophy (NA) and normal morphology served as controls. Bulk RNA‐Sequencing (RNA‐Seq) was performed on a subset of samples. Results Our study highlights the significance of MHC‐1, MHC‐2 and ICAM‐1 in diagnosing IIM subtypes and reveals distinct immunological profiles. RNASeq confirmed the precision of our method and identified specific gene pathways in the disease subtypes. Notably, ASyS, DM and SARS‐CoV‐2‐associated myopathy showed increased ICAM‐1 expression in the endomysial capillaries, indicating ICAM‐1‐associated vascular activation in these conditions. In addition, ICAM‐1 showed high discrimination between different subgroups with high sensitivity and specificity. Conclusions Automated morphometric analysis provides precise quantitative data on immune‐associated proteins that can be integrated into our pathophysiological understanding of IIM. Further, ICAM‐1 holds diagnostic value for the detection of IIM pathology.

Circulating extracellular vesicles and small non-coding RNAs cargo in idiopathic inflammatory myopathies reveal differences across myositis subsets

Predictors of Progression in Idiopathic Inflammatory Myopathies with Interstitial Lung Disease

MicroRNA and mRNA profiling in the idiopathic inflammatory myopathies

Serum cytokine profiles of adults with idiopathic inflammatory myopathies

Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis

The muscle tissue transcriptome of idiopathic inflammatory myopathy reflects the muscle damage process by monocytes and presence of skin lesions

Type 1 interferon signature in peripheral blood mononuclear cells and monocytes of idiopathic inflammatory myopathy patients with different myositis-specific autoantibodies

Differentiating idiopathic inflammatory myopathies by automated morphometric analysis of MHC‐1, MHC‐2 and ICAM‐1 in muscle tissue

High-Dimensional Analysis Reveals Distinct Endotypes in Patients With Idiopathic Inflammatory Myopathies

Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy

Nailfold capillaroscopy findings of a multicentric multi-ethnic cohort of patients with idiopathic inflammatory myopathies

Identification of Novel Associations and Localization of Signals in Idiopathic Inflammatory Myopathies Using Genome-Wide Imputation

Peripheral Blood Lymphocyte Subsets and Heterogeneity of B Cell Subsets in Patients of Idiopathic Inflammatory Myositis with Different Myositis-specific Autoantibodies

Phenotyping of myocardial involvement by cardiac magnetic resonance in idiopathic inflammatory myopathies

Pathogenic mechanisms of disease in idiopathic inflammatory myopathies: autoantibodies as clues

Magnetic Resonance Imaging Patterns Revealing Muscle Pathology and Clinical Features in Idiopathic Inflammatory Myopathies

P049 Proteomic characterization of serum extracellular vesicles from newly diagnosed patients with inflammatory bowel disease

IFNγ causes mitochondrial dysfunction and oxidative stress in myositis

Nailfold Capillaroscopy Changes in Patients with Idiopathic Inflammatory Myopathies

TCRβ clones in muscle tissue share structural features in patients with idiopathic inflammatory myopathy and are associated with disease activity

Clinicopathological and Circulating Cell‐free DNA Profile in Myositis Associated with Anti‐mitochondrial Antibody